These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11858930)

  • 41. Conservative management of delayed, multicomponent coagulopathy following rattlesnake envenomation.
    Camilleri C; Offerman S; Gosselin R; Albertson T
    Clin Toxicol (Phila); 2005; 43(3):201-6. PubMed ID: 15902796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An examination of serial urinalyses in patients with North American crotalid envenomation.
    Moss ST; Bogdan G; Nordt SP; Williams SR; Dart RC; Clark RF
    J Toxicol Clin Toxicol; 1998; 36(4):329-35. PubMed ID: 9711199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Approach to the patient with severe rattlesnake envenomation.
    Bates MC; Wedin GP; Warren SG; Seidler DE
    W V Med J; 1988 Sep; 84(9):398-403. PubMed ID: 3176442
    [No Abstract]   [Full Text] [Related]  

  • 44. Envenomation by the Northern Blacktail Rattlesnake (Crotalus molossus molossus): case report.
    Yarema MC; Curry SC
    Pediatr Emerg Care; 2005 Jan; 21(1):40-2. PubMed ID: 15643324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repeated administrations of crotalid Fab antivenin in the same patient.
    Wilson L
    Am J Emerg Med; 2002 Oct; 20(6):572. PubMed ID: 12369039
    [No Abstract]   [Full Text] [Related]  

  • 46. Acute hypersensitivity reactions associated with administration of crotalidae polyvalent immune Fab antivenom.
    Cannon R; Ruha AM; Kashani J
    Ann Emerg Med; 2008 Apr; 51(4):407-11. PubMed ID: 18191286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pygmy rattlesnake envenomation treated with Crotalidae Polyvalent Immune Fab Antivenom.
    King AM; Crim WS; Menke NB; Pizon AF
    Toxicon; 2012 Dec; 60(7):1287-9. PubMed ID: 22963729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation.
    Offerman SR; Bush SP; Moynihan JA; Clark RF
    Pediatrics; 2002 Nov; 110(5):968-71. PubMed ID: 12415038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pitviper Envenomation Guidelines Should Address Choice Between FDA-approved Treatments for Cases at Risk of Late Coagulopathy.
    Boyer LV; Ruha AM
    Wilderness Environ Med; 2016 Jun; 27(2):341-2. PubMed ID: 27079732
    [No Abstract]   [Full Text] [Related]  

  • 50. Re: Effect of antivenin dose on outcome from crotalid envenomation.
    Woods C; Seibold K
    J Vet Emerg Crit Care (San Antonio); 2010 Aug; 20(4):375. PubMed ID: 20731801
    [No Abstract]   [Full Text] [Related]  

  • 51. Use of CroFab antivenin in the management of a very young pediatric copperhead envenomation.
    Trinh HH; Hack JB
    J Emerg Med; 2005 Aug; 29(2):159-62. PubMed ID: 16029826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Role of antivenoms in the treatment of snake envenomation].
    Chippaux JP
    Bull Acad Natl Med; 2013; 197(4-5):993-1006; discussion 1006-8. PubMed ID: 25518165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of viper bites--a new antiserum based on an affinity purified F(ab) ovine immunoglobulin].
    Jacobsen P; Hein HO
    Ugeskr Laeger; 1995 Apr; 157(14):2025-6. PubMed ID: 7740651
    [No Abstract]   [Full Text] [Related]  

  • 54. Unpredicted late-, new-onset thrombocytopenia and hypofibrinogenemia in Fab antivenom-treated rattlesnake envenomation.
    Seifert SA; Mascarenas DN; Fullerton L; Warrick BJ; Smolinske SC
    Toxicon; 2020 Sep; 184():55-56. PubMed ID: 32505639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrent coagulopathy and thrombocytopenia in children treated with crotalidae polyvalent immune fab: a case series.
    Miller AD; Young MC; DeMott MC; Ly BT; Clark RF
    Pediatr Emerg Care; 2010 Aug; 26(8):576-82. PubMed ID: 20693856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe rattlesnake envenomation with anaphylaxis and rhabdomyolysis.
    Bush SP; Jansen PW
    Ann Emerg Med; 1995 Jun; 25(6):845-8. PubMed ID: 7755213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial.
    Bush SP; Ruha AM; Seifert SA; Morgan DL; Lewis BJ; Arnold TC; Clark RF; Meggs WJ; Toschlog EA; Borron SW; Figge GR; Sollee DR; Shirazi FM; Wolk R; de Chazal I; Quan D; García-Ubbelohde W; Alagón A; Gerkin RD; Boyer LV
    Clin Toxicol (Phila); 2015 Jan; 53(1):37-45. PubMed ID: 25361165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrent and persistent coagulopathy following pit viper envenomation.
    Boyer LV; Seifert SA; Clark RF; McNally JT; Williams SR; Nordt SP; Walter FG; Dart RC
    Arch Intern Med; 1999 Apr; 159(7):706-10. PubMed ID: 10218750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In response to: comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial.
    Fernandez D; Al Ameri F; Su MK
    Clin Toxicol (Phila); 2015 May; 53(4):413. PubMed ID: 25723894
    [No Abstract]   [Full Text] [Related]  

  • 60. In reply re: "comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial".
    Bush SP; Ruha AM; Seifert SA; Sollee DR; Boyer LV
    Clin Toxicol (Phila); 2015 May; 53(4):414-5. PubMed ID: 25706452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.